| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 213 | 237 | 249 | 250 | 248 | 287 | 284 | 264 | 267 | 324 | 334 | 297 | 382 | 374 | 349 | 401 | 396 | 405 | 412 | 429 | 417 | 478 | 461 | 462 | 425 | 432 | 404 | 386 | 431 |
| Expenses | 206 | 224 | 238 | 224 | 230 | 260 | 255 | 239 | 227 | 268 | 272 | 250 | 300 | 300 | 285 | 329 | 337 | 345 | 337 | 363 | 365 | 410 | 405 | 401 | 384 | 392 | 399 | 391 | 420 |
| EBITDA | 7 | 13 | 11 | 26 | 18 | 27 | 30 | 25 | 40 | 56 | 62 | 47 | 82 | 74 | 65 | 72 | 60 | 60 | 74 | 66 | 52 | 68 | 56 | 61 | 42 | 40 | 6 | -5 | 10 |
| Operating Profit % | 3 % | 5 % | 4 % | 9 % | 7 % | 9 % | 10 % | 9 % | 15 % | 17 % | 18 % | 15 % | 21 % | 19 % | 18 % | 18 % | 15 % | 15 % | 18 % | 15 % | 12 % | 13 % | 12 % | 9 % | 10 % | 9 % | 1 % | -2 % | 2 % |
| Depreciation | 17 | 18 | 18 | 20 | 17 | 18 | 18 | 18 | 19 | 19 | 17 | 19 | 22 | 20 | 19 | 18 | 20 | 16 | 17 | 18 | 20 | 21 | 24 | 26 | 28 | 29 | 29 | 29 | 30 |
| Interest | 7 | 5 | 4 | 5 | 6 | 5 | 7 | 8 | 6 | 6 | 6 | 5 | 4 | 3 | 4 | 3 | 4 | 5 | 7 | 9 | 8 | 8 | 10 | 12 | 14 | 18 | 16 | 18 | 26 |
| Profit Before Tax | -12 | -10 | 4 | 9 | -0 | 10 | 11 | 8 | 24 | 37 | 38 | 34 | 61 | 65 | 51 | 60 | 48 | 67 | 38 | 39 | 34 | 46 | 23 | 33 | 7 | -5 | -31 | -46 | -37 |
| Tax | 0 | -3 | -1 | -2 | -2 | 2 | 2 | 2 | 7 | 11 | 12 | 9 | 22 | 23 | 18 | 19 | 10 | 18 | 10 | 13 | 10 | 11 | 7 | 11 | 5 | 5 | -3 | -4 | -0 |
| Net Profit | -12 | -7 | 5 | 12 | 2 | 8 | 9 | 5 | 17 | 26 | 25 | 25 | 40 | 42 | 33 | 41 | 39 | 50 | 28 | 26 | 24 | 35 | 16 | 22 | 2 | -10 | -28 | -41 | -36 |
| EPS in ₹ | -1.32 | -0.81 | 0.57 | 1.25 | 0.20 | 0.85 | 0.99 | 0.58 | 1.85 | 2.78 | 2.75 | 2.71 | 4.30 | 4.52 | 3.58 | 4.39 | 4.19 | 5.40 | 3.05 | 2.80 | 2.62 | 3.82 | 1.69 | 2.39 | 0.20 | -1.09 | -3.08 | -4.48 | -3.94 |
Indoco Remedies
Indoco Remedies
311.35
-5.80
(-1.83%)
Q1 Quarterly Results are out. Check out the updated financials8 hours ago
Show All
Market Cap
2,872.14 Cr
EPS
-8.46
PE Ratio
126.00
Dividend Yield
0.06 %
Industry
Healthcare52 Week High
387.55
52 Week Low
190.00
PB Ratio
2.86
Debt to Equity
0.47
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from5 analysts
Company News
View All News
Indoco Remedies Plans 4-5 New Product Filings, Debt Reduction of Rs 68 Crore3 days ago
Indoco Remedies announced plans to file 4-5 new products in FY26. The company's management expects to repay Rs 68 crore of debt in the remaining nine months of FY26. For its domestic business, the company expects to add at least 25,000 per man in incremental PHY by year end. The company plans to limit capital expenditure going forward, with only Rs 50 crore incremental capex expected this year, focused on ongoing projects at Goa Plant 2 and the API site for Warren Remedies.
Indoco Remedies Reports Q1 Net Loss of 358M Rupees Against Previous Year's Profit4 days ago
Indoco Remedies reported a consolidated net loss of 358 million rupees in Q1 compared to a profit of 26.2 million rupees in the same quarter last year. Revenue increased marginally to 4.4 billion rupees from 4.3 billion rupees year-over-year. EBITDA declined significantly to 103.5 million rupees from 364.5 million rupees, with EBITDA margin dropping to 2.41% from 8.59% in the previous year.
Indoco Remedies Limited reported quarterly results showing revenue from operations of Rs 38,383 lakhs, representing a 12.5% growth compared to the previous quarter's Rs 34,107 lakhs. However, the company recorded a loss before tax of Rs 2,840 lakhs, contrasting with a profit of Rs 1,951 lakhs in the same quarter of the previous year. The net loss for the period was Rs 2,806 lakhs compared to a profit of Rs 1,495 lakhs in the prior year quarter. EBITDA improved to Rs 148 million from Rs 35 million in the previous quarter. The company operates in the pharmaceuticals segment with revenue split between India (Rs 22,256 lakhs) and outside India (Rs 16,127 lakhs). Two subsidiaries, FPP Holding LLC and Warren Remedies Private Limited, reported significant losses and negative net worth, raising going concern uncertainties, though management believes no impairment provision is necessary based on their assessment.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,702.20 | #1 4,08,414.80 | 35.57 | #1 54,729.00 | 12.06 | #1 10,980 | -18.99 | 55.97 | |
6,584.00 | 1,74,784.51 | 80.22 | 9,712.00 | 0.89 | 2,191 | 23.05 | 40.37 | |
1,572.00 | 1,26,971.67 | 22.93 | 28,409.50 | 7.12 | 5,291 | 9.88 | 70.77 | |
3,622.90 | 1,21,969.00 | 63.65 | 11,539.40 | 6.99 | 1,911 | 19.91 | 72.46 | |
1,287.40 | 1,07,442.68 | #1 18.77 | 33,741.20 | 16.73 | 5,725 | 1.26 | 54.50 | |
2,541.60 | 1,04,899.14 | 61.83 | 12,744.20 | 19.57 | 2,007 | -10.91 | 52.39 | |
980.10 | 98,620.99 | 21.15 | 23,511.00 | 13.82 | 4,615 | -0.19 | 54.96 | |
1,960.50 | 89,535.15 | 27.44 | 22,909.50 | #1 19.94 | 3,306 | #1 112.49 | 53.75 | |
32,895.00 | 69,899.58 | 50.72 | 6,684.70 | 10.80 | 1,414 | 27.83 | 42.22 | |
1,127.00 | 65,456.34 | 18.86 | 31,378.10 | 17.55 | 3,366 | -0.50 | 47.15 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
9.35 %
Net Income Growth
-31.83 %
Cash Flow Change
-12.37 %
ROE
-36.80 %
ROCE
-35.79 %
EBITDA Margin (Avg.)
-19.41 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 846 | 941 | 1,197 | 1,238 | 1,258 | 1,272 | 1,315 | 1,486 | 1,658 | 2,145 | 2,430 |
| Fixed Assets | 340 | 374 | 440 | 489 | 468 | 590 | 570 | 555 | 678 | 954 | 1,296 |
| Current Assets | 385 | 465 | 572 | 539 | 538 | 563 | 623 | 774 | 814 | 955 | 1,001 |
| Capital Work in Progress | 63 | 55 | 91 | 136 | 185 | 51 | 68 | 122 | 114 | 125 | 276 |
| Investments | 0 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 9 | 419 |
| Other Assets | 443 | 496 | 666 | 614 | 605 | 631 | 677 | 809 | 864 | 1,057 | 0 |
| Total Liabilities | 846 | 941 | 1,197 | 1,238 | 1,258 | 1,272 | 1,315 | 1,486 | 1,658 | 2,145 | 2,430 |
| Current Liabilities | 262 | 303 | 390 | 417 | 446 | 459 | 407 | 425 | 425 | 612 | 808 |
| Non Current Liabilities | 65 | 61 | 155 | 146 | 152 | 133 | 139 | 157 | 205 | 422 | 604 |
| Total Equity | 519 | 577 | 651 | 675 | 661 | 680 | 769 | 905 | 1,028 | 1,111 | 1,022 |
| Reserve & Surplus | 500 | 558 | 633 | 657 | 642 | 661 | 751 | 886 | 1,010 | 1,092 | 1,004 |
| Share Capital | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 19 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 1 | -0 | 50 | -52 | 12 | 3 | -14 | 8 | -7 | 4 |
| Investing Activities | -88 | -111 | -171 | -135 | -104 | -56 | -67 | -121 | -208 | -433 |
| Operating Activities | 109 | 112 | 89 | 123 | 132 | 123 | 82 | 174 | 179 | 157 |
| Financing Activities | -20 | -2 | 132 | -39 | -16 | -64 | -30 | -44 | 23 | 280 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 58.69 % | 58.69 % | 58.69 % | 58.69 % | 58.69 % | 58.69 % | 58.69 % | 58.69 % | 58.69 % | 58.74 % | 58.74 % | 58.72 % | 58.75 % | 58.75 % | 58.80 % | 58.90 % | 58.90 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.12 % | 0.12 % | 1.59 % | 1.69 % | 1.91 % | 1.47 % | 1.70 % | 1.25 % | 1.24 % | 1.22 % |
| DIIs | 18.88 % | 18.80 % | 17.22 % | 17.23 % | 17.64 % | 17.52 % | 17.33 % | 18.07 % | 17.29 % | 17.78 % | 19.56 % | 19.41 % | 18.67 % | 18.24 % | 18.90 % | 18.75 % | 18.96 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 15.92 % | 15.92 % | 17.32 % | 17.87 % | 17.87 % | 17.23 % | 16.85 % | 16.74 % | 16.48 % | 16.84 % | 15.24 % | 15.33 % | 16.29 % | 16.30 % | 16.07 % | 15.99 % | 15.79 % |
| Others | 6.52 % | 6.59 % | 6.78 % | 6.21 % | 5.80 % | 6.57 % | 7.13 % | 6.39 % | 7.42 % | 5.04 % | 4.77 % | 4.62 % | 4.81 % | 5.01 % | 4.99 % | 5.12 % | 5.14 % |
| No of Share Holders | 21,508 | 24,518 | 34,746 | 37,279 | 37,863 | 38,498 | 38,072 | 35,713 | 34,731 | 36,588 | 32,600 | 33,201 | 34,511 | 34,416 | 34,676 | 34,497 | 33,129 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 1.6 | 1 | 0.3 | 0.3 | 1.5 | 2.25 | 2.25 | 1.5 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.75 | 0.49 | 0.14 | 0.1 | 0.4 | 0.69 | 0.68 | 0.64 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 24 Jul 2025 |  Quarterly Result Announcement | NA | 24 Jul 2025 | 325.90 | 310.05 |
| 22 May 2025 | Quarterly Result Announcement | NA | 22 May 2025 | 251.12 | 261.58 |
| 21 Jan 2025 | Quarterly Result Announcement | NA | 21 Jan 2025 | 326.65 | 335.15 |
| 24 Oct 2024 | Quarterly Result Announcement | NA | 24 Oct 2024 | 336.65 | 319.95 |
| 26 Sept 2024 |  Annual General Meeting | NA | 26 Sept 2024 | 365.50 | 365.50 |
| 19 Sept 2024 |  Dividend | ₹ 1.50 /share | 19 Sept 2024 | 327.55 | 369.65 |
| 19 Sept 2023 | Dividend | ₹ 2.25 /share | 18 Sept 2023 | 347.80 | 356.80 |
| 16 Sept 2022 | Dividend | ₹ 0.75 /share | 14 Sept 2022 | 331.60 | 359.35 |
| 15 Sept 2022 | Dividend | ₹ 1.50 /share | 14 Sept 2022 | 331.60 | 365.20 |
| 21 Sept 2021 | Dividend | ₹ 1.50 /share | 17 Sept 2021 | 358.65 | 473.05 |
Announcements
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
20 hours ago
20 hours agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome4 days ago
4 days agoFinancial Results For The Quarter Ended 30Th June 20254 days ago
4 days agoBoard Meeting Outcome for Outcome Of Board Meeting Held On 24Th July 20254 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 16, 2025
Jul 16, 2025Board Meeting Intimation for Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter Ended 30-06-2025.Jul 14, 2025
Jul 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Jul 09, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 03, 2025
Jul 03, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 03, 2025
Jul 03, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 03, 2025
Jul 03, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Intimation To Shareholders Holding Shares In Physical Mode Regarding Mandatory Furnishing Of PAN KYC And Bank Details As Per SEBI Master Circular No. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 Dated May 07 2024 And SEBI Circular Bearing Reference No. SEBI/HO/MIRSDJun 24, 2025
Jun 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 19, 2025
Jun 19, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 13, 2025
Jun 13, 2025Announcement Under Regulation 30 (LODR):- Order For Drop Of Proceeding Under GST Act 2017Jun 12, 2025
Jun 12, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 12, 2025
Jun 12, 2025Order For Drop Of ProceedingJun 11, 2025
Jun 11, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 03, 2025
Jun 03, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 26, 2025
May 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 22, 2025
May 22, 2025Appointment Of Secretarial Auditor And Internal Auditor Of The CompanyMay 22, 2025
May 22, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateMay 22, 2025
May 22, 2025Financial Results For The Year Ended 31St March 2025May 22, 2025
May 22, 2025Board Meeting Outcome for Financial Results For The Year Ended 31St March 2025 And Recommendation Of A Final DividendMay 22, 2025
May 22, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 15, 2025
May 15, 2025Board Meeting Intimation for Audited Results & DividendMay 14, 2025
May 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Apr 07, 2025Closure of Trading WindowMar 28, 2025
Mar 28, 2025Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations2015 (Listing Regulations)Mar 27, 2025
Mar 27, 2025Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Mar 25, 2025
Mar 25, 2025Intimation Of Appointment Of Cost Auditor Of The Company Pursuant To Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 25, 2025
Mar 25, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 21, 2025
Mar 21, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 19, 2025
Mar 19, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 12, 2025
Mar 12, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 12, 2025
Mar 12, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 11, 2025
Mar 11, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 10, 2025
Mar 10, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 10, 2025
Mar 10, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 07, 2025
Mar 07, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 05, 2025
Mar 05, 2025REVISED DISCLOSURE UNDER REGULATION 30 OF THE SEBI (LODR) REGULATIONS2015 (LISTING REGULATIONS)
Feb 28, 2025
Feb 28, 2025DISCLOSURE UNDER REGULATION 30 OF THE SEBI (LODR) REGULATIONS2015 (LISTING REGULATIONS)Feb 25, 2025
Feb 25, 2025DISCLOSURE UNDER REGULATION 30 OF THE SEBI (LODR) REGULATIONS2015 (LISTING REGULATIONS)Feb 25, 2025
Feb 25, 2025Technical Indicators
RSI(14)
Neutral 49.78
ATR(14)
Volatile 14.74
STOCH(9,6)
Neutral 25.29
STOCH RSI(14)
Oversold 11.00
MACD(12,26)
Bearish -3.70
ADX(14)
Strong Trend 33.34
UO(9)
Bearish 42.14
ROC(12)
Downtrend And Accelerating -6.45
WillR(14)
Neutral -64.30
Mutual Fund Holdings
DSP Multicap Fund Direct - Growth 
Bandhan BSE Healthcare Index Fund Direct-Growth 
ICICI Prudential MNC Fund Direct - Growth 
Franklin India Small Cap Fund Direct-Growth 
Groww Nifty Total Market Index Fund Direct - Growth 
HDFC Multi Cap Fund Direct - Growth 
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth 
Nippon India Pharma Fund Direct-Growth 
Quant Small Cap Fund Direct Plan-Growth 
Tata India Innovation Fund Direct-Growth 
UTI Healthcare Fund Direct-Growth 
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
